One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2019-126606
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 3 |
Affiliation: University Hospital Ostrava, University of Ostrava, Takeda (United States), Millennium Engineering and Integration (United States), National and Kapodistrian University of Athens, New York University Langone Medical Center, Karmanos Cancer Institute, Wayne State University, Alfred Health, Monash University, Centre Hospitalier Universitaire de Poitiers, Levine Cancer Institute, The University of Texas MD Anderson Cancer Center, NIHR Leeds In Vitro Diagnostics Co-operative, Icahn School of Medicine at Mount Sinai, University of Arkansas for Medical Sciences, Indiana University – Purdue University Indianapolis, University of Turin, Rocky Mountain Cancer Centers, Valley Medical Center, São Germano Oncologia, Pilsen Tools (Czechia), Aurora Health Care, University Hospital Olomouc, Charles University, General University Hospital in Prague, Peking University, Peking University People's Hospital, Universität Hamburg, University Medical Center Hamburg-Eppendorf, Hospital Pablo Tobon Uribe, Masaryk University, Instituto de Investigación Biomédica de Salamanca, Sarah Cannon, University of California, San Diego, University Hospital Brno
Closing the Efficacy and Effectiveness Gap: Outcomes in Relapsed/Refractory Multiple Myeloma (RRMM) Patients (Pts) Treated with Ixazomib-Lenalidomide-Dexamethasone (IRd) in Routine Clinical Practice Remain Comparable to the Outcomes Reported in the Phase 3 Tourmaline-MM1 Study
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
